Mediators of Inflammation (Jan 2021)

Tryptophan-Kynurenine Pathway in COVID-19-Dependent Musculoskeletal Pathology: A Minireview

  • Sagar Vyavahare,
  • Sandeep Kumar,
  • Nicholas Cantu,
  • Ravindra Kolhe,
  • Wendy B. Bollag,
  • Meghan E. McGee-Lawrence,
  • William D. Hill,
  • Mark W. Hamrick,
  • Carlos M. Isales,
  • Sadanand Fulzele

DOI
https://doi.org/10.1155/2021/2911578
Journal volume & issue
Vol. 2021

Abstract

Read online

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), affecting multiple organ systems, including the respiratory tract and lungs. Several studies have reported that the tryptophan-kynurenine pathway is altered in COVID-19 patients. The tryptophan-kynurenine pathway plays a vital role in regulating inflammation, metabolism, immune responses, and musculoskeletal system biology. In this minireview, we surmise the effects of the kynurenine pathway in COVID-19 patients and how this pathway might impact muscle and bone biology.